In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B

por Trepanier, Daniel J., Ure, Daren R., Foster, Robert T.
Publicado 2017

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models

por Kuo, Joseph, Bobardt, Michael, Chatterji, Udayan, Mayo, Patrick R., Trepanier, Daniel J., Foster, Robert T., Gallay, Philippe, Ure, Daren R.
Publicado 2019

Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets

por Kolic, Jelena, Beet, Leanne, Overby, Peter, Cen, Haoning Howard, Panzhinskiy, Evgeniy, Ure, Daren R, Cross, Jennifer L, Huizinga, Robert B, Johnson, James D
Publicado 2020

Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH

por Harrison, Stephen A., Mayo, Patrick R., Hobbs, Todd M., Canizares, Carlos, Foster, Erin P., Zhao, Caroline, Ure, Daren R., Trepanier, Daniel J., Greytok, Jill A., Foster, Robert T.
Publicado 2022